• Study on Efinopegdutide and Semaglutide for Adults with Non-Alcoholic Steatohepatitis (NASH) Before Cirrhosis

    Not recruiting

    2 1 1
    Investigated Drugs:
    Austria Belgium Czechia France Hungary Italy +2

  • Study of Ripretinib vs Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumor with Specific KIT Exon Mutations Previously Treated with Imatinib

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    France Germany Hungary Italy The Netherlands Norway +2

  • Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Greece +5

  • Study Comparing Setrusumab and Bisphosphonates for Children with Osteogenesis Imperfecta

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy The Netherlands Poland

  • Study on Long-Term Safety of Ligelizumab for Patients with Food Allergies

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy The Netherlands Spain

  • Study Comparing Gadoquatrane with Gadoteric Acid, Gadoteridol, and Gadobutrol for MRI in Patients with Non-CNS Conditions

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia France Germany Hungary Italy +2

  • Study of Tislelizumab, LBL-007, and BGB-15025 in Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Romania Spain

  • Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Bulgaria Czechia Estonia France Germany +8

  • Study of MK-7684A, Etoposide, and Platinum Drugs for Patients with Extensive-Stage Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Finland France Germany Greece Hungary +8

  • Study Comparing Tisagenlecleucel with Standard Treatment for Adults with Relapsed or Refractory Follicular Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Czechia Hungary Poland Romania Slovakia +1

powered by